Literature DB >> 7107131

Sympathetic ophthalmia: a comparison of the histopathological features from a Chinese and American series.

P K Kuo, J R Lubin, C Ni, K M Wang, D M Albert.   

Abstract

The importance of this comparison between two large series of cases of sympathetic ophthalmia lies in its confirmation of our previous findings, which differ somewhat from the classical pathological description. Sympathetic ophthalmia remains a clinicopathological diagnosis, relying on a history of perforating injury to one eye, followed after a variable incubation period by inflammation in the fellow eye. The inflammatory changes in both eyes consist of a diffuse, granulomatous proliferation throughout the uveal tract, which involves the choriocapillaris and the retina late in its course. The infiltrate is composed predominantly of lymphocytes and plasma cells, with a variable number of epitheloid and giant cells. Corticosteroid therapy may modify this picture. The epithelioid cells contain phagocytosed pigment granules, but there is not sign of necrosis. Eosinophils appear early in the course of the disease and disappear late. The granulomatous inflammation may spread to involve the optic nerve sheath, the nerve itself, the scleral emissaria, and the scleral stroma. Dalén-Fuchs nodules appear early peripherally, and it is over these nodules that retinal granulomas, when present, usually are found. In the Shanghai series, it was found that corticosteroid therapy and prompt enucleation of the exciting eye reduced the number of exacerbations experienced by these patients but did not improve visual prognosis. The MEEI data, while they did show a bimodal distribution to the visual result, seemed to indicate that prompt enucleation of a blind eye combined with aggressive corticosteroid therapy may improve visual prognosis.

Entities:  

Mesh:

Year:  1982        PMID: 7107131     DOI: 10.1097/00004397-198202230-00010

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


  4 in total

Review 1.  Sympathetic ophthalmia: an autoimmune ocular inflammatory disease.

Authors:  C C Chan; M Mochizuki
Journal:  Springer Semin Immunopathol       Date:  1999

2.  SYMPATHETIC OPHTHALMIA: Clinicopathologic Correlation in a Consecutive Case Series.

Authors:  Hassan A Aziz; Harry W Flynn; Ryan C Young; Janet L Davis; Sander R Dubovy
Journal:  Retina       Date:  2015-08       Impact factor: 4.256

3.  Sympathetic ophthalmia: what have we learned?

Authors:  H Nida Sen; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2009-11       Impact factor: 5.258

Review 4.  Sympathetic ophthalmia.

Authors:  Claudia Patricia Castiblanco; Ron A Adelman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-16       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.